Correlation between patients’ age and cancer immunotherapy efficacy

Correlation between patients’ age and cancer immunotherapy efficacy

Background: Although immunosenescence-induced difference on overall immune function and immune cell subsets between younger and older populations has been well characterized, the potential effect of patients’ age on the efficacy of immune checkpoint inhibitors (ICIs) remains little known. We perform...

Full description

Bibliographic Details
Main Authors: Qiong Wu, Qiuhong Wang, Xin Tang, Ran Xu, Luzhong Zhang, Xinming Chen, Qun Xue, Ziheng Wang, Rongfeng Shi, Feiran Wang, Fei Ju, Bo Zhang, You Lang Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2019-04-01
Series:OncoImmunology
Subjects:
immune checkpoint inhibitor
overall survival
progression-free survival
immunosenescence
age
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1568810

Internet

http://dx.doi.org/10.1080/2162402X.2019.1568810

Similar Items